These medications were originally created to treat type 2 diabetes, but emerging research shows they may also support weight loss and metabolic health for people living with PCOS
Targets 17 , 437448 (2013)
After reconstitution, refrigerate at 2-8C protected from light and use within 14 days
In the main per-protocol analyses, participants were followed from the index date to first mutually exclusive incidence of SIS, discontinuation of study drug (defined as more than 60 days without drug supply), initiation of other study drug, or switch to other glucose-lowering drug (defined as filling a prescription for any glucose-lowering drug other than the baseline treatment or metformin and not refilling the assigned drug for 60 days), death, or end of follow-up
Administration Instructions Intramuscular Injection Instructions Subcutaneous Injection Instructions Related medications 503A vs 503B 503A pharmacies compound products for specific patients whose prescriptions are sent by their healthcare provider